Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1993-6-3
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0007-1250
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
162
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
566
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8329060-Clozapine,
pubmed-meshheading:8329060-Diagnosis, Differential,
pubmed-meshheading:8329060-Humans,
pubmed-meshheading:8329060-Neuroleptic Malignant Syndrome,
pubmed-meshheading:8329060-Risk Factors,
pubmed-meshheading:8329060-Schizophrenia,
pubmed-meshheading:8329060-Schizophrenic Psychology
|
pubmed:year |
1993
|
pubmed:articleTitle |
Clozapine and NMS.
|
pubmed:publicationType |
Letter,
Comment
|